Mainly engaged in research on the pharmacodynamic material basis, quality control, in vivo metabolism, biological functions and innovative traditional Chinese medicines of traditional Chinese medicines and compound prescriptions, and presided over 16 funds including the National 863 Fund, the National Natural Science Foundation, and the National New Drug Fund. subject. He has published 182 papers at home and abroad, including 100 papers in SCI-collected magazines such as Journal of Natural Products and Planta Medica, 5 papers in EI, and 2 monographs. Won 6 Shanghai Science and Technology Progress Awards and the second and third prizes of the Military Science and Technology Progress Awards. 20 domestic invention patents and 1 international invention patent. Obtained 3 clinical approvals for Class I new drugs of traditional Chinese medicine, and 6 Class II and III new drug certificates and clinical approvals.